Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome.

Bannister EG, Yuen L, Littlejohn M, Edwards R, Sozzi V, Colledge D, Li X, Locarnini S, Hardikar W, Revill PA.

J Gen Virol. 2018 Aug;99(8):1103-1114. doi: 10.1099/jgv.0.001086. Epub 2018 Jun 22.

PMID:
29932395
2.

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.

Sozzi V, Shen F, Chen J, Colledge D, Jackson K, Locarnini S, Yuan Z, Revill PA.

Virology. 2018 Jun;519:190-196. doi: 10.1016/j.virol.2018.04.015. Epub 2018 May 4.

PMID:
29734042
3.

Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.

Shen F, Li Y, Wang Y, Sozzi V, Revill PA, Liu J, Gao L, Yang G, Lu M, Sutter K, Dittmer U, Chen J, Yuan Z.

Hepatology. 2018 Apr;67(4):1237-1252. doi: 10.1002/hep.29609. Epub 2018 Feb 22.

PMID:
29059468
4.

Vestibular Schwannoma Resection with Ipsilateral Simultaneous Cochlear Implantation in Patients with Normal Contralateral Hearing.

Sanna M, Medina MD, Macak A, Rossi G, Sozzi V, Prasad SC.

Audiol Neurootol. 2016;21(5):286-295. doi: 10.1159/000448583. Epub 2016 Nov 5.

PMID:
27816972
5.

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes.

Sozzi V, Walsh R, Littlejohn M, Colledge D, Jackson K, Warner N, Yuen L, Locarnini SA, Revill PA.

J Virol. 2016 Oct 28;90(22):10054-10064. Print 2016 Nov 15.

6.

Bone anchored hearing implants without skin thinning: the Gruppo Otologico surgical and audiological experience.

Caruso A, Giannuzzi AL, Sozzi V, Sanna M.

Eur Arch Otorhinolaryngol. 2017 Feb;274(2):695-700. doi: 10.1007/s00405-016-4305-x. Epub 2016 Sep 14.

PMID:
27637751
7.

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HLA, Gane E, Sozzi V, Colledge D, Hammond R, Edwards R, Locarnini S, Thompson A, Revill PA.

Gut. 2017 Nov;66(11):2013-2023. doi: 10.1136/gutjnl-2015-309300. Epub 2016 Aug 17.

PMID:
27534671
8.

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

Betz-Stablein BD, Töpfer A, Littlejohn M, Yuen L, Colledge D, Sozzi V, Angus P, Thompson A, Revill P, Beerenwinkel N, Warner N, Luciani F.

J Virol. 2016 Jul 27;90(16):7171-7183. doi: 10.1128/JVI.00243-16. Print 2016 Aug 15.

9.

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, De Rose R, Navis M, Winnall WR, Kramski M, Bernardi G, Bayliss J, Colledge D, Sozzi V, Visvanathan K, Locarnini SA, Kent SJ, Revill PA.

J Virol. 2014 Sep;88(18):10412-20. doi: 10.1128/JVI.00111-14. Epub 2014 May 28.

10.

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.

Li W, Warner N, Sozzi V, Yuen L, Colledge D, Li T, Zhuang H, Locarnini S, Revill PA.

Hepatol Int. 2013 Jun;7(2):443-50. doi: 10.1007/s12072-012-9411-2. Epub 2012 Nov 28.

PMID:
26201776
11.

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.

Cabuang LM, Shaw T, Littlejohn M, Colledge D, Sozzi V, Soppe S, Warner N, Thompson A, Preiss S, Lam N, Walsh R, Lewin SR, Thio CL, Matthews G, Locarnini SA, Revill PA.

J Med Virol. 2012 Aug;84(8):1166-76. doi: 10.1002/jmv.23328.

12.

Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.

Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K.

Hepatology. 2009 May;49(5):1483-91. doi: 10.1002/hep.22796.

PMID:
19274751
13.

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Preiss S, Littlejohn M, Angus P, Thompson A, Desmond P, Lewin SR, Sasadeusz J, Matthews G, Dore GJ, Shaw T, Sozzi V, Yuen L, Lau G, Ayres A, Thio C, Avihingsanon A, Ruxrungtham K, Locarnini S, Revill PA.

Hepatology. 2008 Sep;48(3):741-9. doi: 10.1002/hep.22386.

14.

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging.

Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, Locarnini SA.

Antiviral Res. 2007 Nov;76(2):168-77. Epub 2007 Jul 24.

PMID:
17709147
15.

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.

Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S.

Hepatology. 2007 Jan;45(1):102-10.

PMID:
17187404
16.

In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.

Chin R, Shaw T, Torresi J, Sozzi V, Trautwein C, Bock T, Manns M, Isom H, Furman P, Locarnini S.

Antimicrob Agents Chemother. 2001 Sep;45(9):2495-501.

17.

Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle.

Cocks TM, Sozzi V, Moffatt JD, Selemidis S.

Gastroenterology. 1999 Mar;116(3):586-92.

PMID:
10029617
18.

Ischaemia/reperfusion enhances phenylephrine-induced contraction of rabbit aorta due to impairment of neuronal uptake.

Sobey CG, Sozzi V, Woodman OL.

J Cardiovasc Pharmacol. 1994 Apr;23(4):562-8.

PMID:
7516005

Supplemental Content

Support Center